Title |
Current Status of Gene Engineering Cell Therapeutics
|
---|---|
Published in |
Frontiers in immunology, February 2018
|
DOI | 10.3389/fimmu.2018.00153 |
Pubmed ID | |
Authors |
Aurore Saudemont, Laurent Jespers, Timothy Clay |
Abstract |
Ex vivo manipulations of autologous patient's cells or gene-engineered cell therapeutics have allowed the development of cell and gene therapy approaches to treat otherwise incurable diseases. These modalities of personalized medicine have already shown great promises including product commercialization for some rare diseases. The transfer of a chimeric antigen receptor or T cell receptor genes into autologous T cells has led to very promising outcomes for some cancers, and particularly for hematological malignancies. In addition, gene-engineered cell therapeutics are also being explored to induce tolerance and regulate inflammation. Here, we review the latest gene-engineered cell therapeutic approaches being currently explored to induce an efficient immune response against cancer cells or viruses by engineering T cells, natural killer cells, gamma delta T cells, or cytokine-induced killer cells and to modulate inflammation using regulatory T cells. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 78 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 13 | 17% |
Student > Ph. D. Student | 12 | 15% |
Student > Master | 9 | 12% |
Researcher | 8 | 10% |
Student > Doctoral Student | 7 | 9% |
Other | 10 | 13% |
Unknown | 19 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 14 | 18% |
Biochemistry, Genetics and Molecular Biology | 13 | 17% |
Medicine and Dentistry | 12 | 15% |
Immunology and Microbiology | 6 | 8% |
Chemistry | 3 | 4% |
Other | 12 | 15% |
Unknown | 18 | 23% |